Noam Feldman from Dr. Shahar Alon's Lab Accepted to Prestigious MD-PhD Program

Noam Feldman, a master’s student in the Faculty of Engineering at Bar-Ilan University, has been accepted to the highly competitive MD-PhD program at the Weizmann Institute of Science. Out of hundreds of applicants, only 20 were selected for this elite program, which integrates medical studies with research training aimed at cultivating physician-scientists.

During her studies at Dr. Shahar Alon’s lab, Noam, together with PhD student Alex Glick, developed an innovative technology that enables precise mapping of patient-derived brain organoids—three-dimensional structures grown from patient cells that aim to replicate key aspects of brain function—without disrupting their architecture. This breakthrough allows for direct comparison between organoids from healthy individuals and those with neurological disorders, advancing the understanding of disease mechanisms and enabling high-throughput drug testing.

“I have always aspired to study medicine, but during my undergraduate research project at Dr. Alon’s lab, I discovered the vast possibilities that scientific inquiry offers,” says Noam. “I realized I didn’t want to choose between medicine and research—I wanted to combine both. This program offers the opportunity to treat patients while contributing to transformative medical research.”

Noam, 25, from Beit Shemesh, possesses a joint bachelor’s degree in neuroscience and life sciences from Bar-Ilan University and is completing her master’s degree under Dr. Alon’s supervision. “Shahar has been a mentor since my undergraduate studies—instilling confidence, encouraging creativity, and driving me toward excellence,” she shares. “His guidance has been central to advancing research with real potential to impact the understanding and treatment of brain diseases."

Looking ahead, Noam will transition from Bar-Ilan to the Weizmann Institute to begin her medical training. She is particularly drawn to the field of fertility medicine, valuing its profound personal and societal impact. “I hope to contribute both through research that can enhance treatments and by supporting patients at meaningful moments in their lives,” she reflects. “This is my dream for now, but I’m open to new directions the journey may reveal.”